Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy

SIMPLE SUMMARY: Gynecological cancers represent a group of malignancies with high incidence and mortality, despite their relative sensitivity to platinum-based chemotherapy. This review aims to illustrate the state of research in the field of immunotherapy, and in particular, deals with the developm...

Descripción completa

Detalles Bibliográficos
Autores principales: Schepisi, Giuseppe, Casadei, Chiara, Toma, Ilaria, Poti, Giulia, Iaia, Maria Laura, Farolfi, Alberto, Conteduca, Vincenza, Lolli, Cristian, Ravaglia, Giorgia, Brighi, Nicole, Altavilla, Amelia, Martinelli, Giovanni, De Giorgi, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922040/
https://www.ncbi.nlm.nih.gov/pubmed/33671294
http://dx.doi.org/10.3390/cancers13040840

Ejemplares similares

Ejemplares similares